✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
591daili 济南圣和化工
Home › Product Catalog › Sorafenib Tosylate

Sorafenib Tosylate

CAS 475207-59-1C28H24ClF3N4O6SMW 637.0

Sorafenib Tosylate (CAS 475207-59-1) — formula C28H24ClF3N4O6S, molecular weight 637.0; category organic chemicals.

Specifications

CAS Number475207-59-1
Molecular FormulaC28H24ClF3N4O6S
Molecular Weight637.0
CategoryOrganic Chemicals

Purchase Profile

What this product is

Sorafenib Tosylate is a carbon-based organic compound with CAS registry number 475207-59-1 and molecular formula C28H24ClF3N4O6S (molecular weight 637.0), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 475207-59-1

Its molecular formula C28H24ClF3N4O6S comprises 28 C, 24 H, 1 Cl, 3 F, 4 N, 6 O, 1 S atoms.

Also known as: Sorafenib Tosylate

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of Sorafenib Tosylate?

The CAS registry number of Sorafenib Tosylate is 475207-59-1.

What is the molecular formula and molecular weight of Sorafenib Tosylate?

Molecular formula C28H24ClF3N4O6S, molecular weight 637.0.

What other names is Sorafenib Tosylate known by?

It is also registered under: Sorafenib Tosylate.

Which category does Sorafenib Tosylate belong to?

Category: Organic Chemicals.

PubChem Public Data

Public-database records for Sorafenib Tosylate (CAS 475207-59-1), reproduced here for independent cross-checking.

Safety classification and hazard statements

Reported hazard statementsH302 (31%), H332 (28.6%), H360 (73.8%), H373 (64.3%), H412 (21.4%)

H302 (31%): Harmful if swallowed [Warning Acute toxicity, oral]

H332 (28.6%): Harmful if inhaled [Warning Acute toxicity, inhalation]

How this substance is indexed

CAS Registry Number475207-59-1
PubChem CID406563
分子式C28H24ClF3N4O6S
IUPAC 名称4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
UNII(FDA)5T62Q3B36J

Documented uses

  • Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma.
  • Breast Feeding; Lactation; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Tyrosine Kinase Inhibitors;
  • Sorafenib tosylate is approved to treat:
  • • Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery.
  • • Renal cell carcinoma (a type of kidney cancer) that is advanced.
  • • Thyroid cancer in certain patients whose cancer has gotten worse, has come back, or has spread to other parts of the body and did not respond to treatment with radioactive iodine.

Names this substance appears under

Sorafenib tosylate; 475207-59-1; Nexavar; Sorafenib tosilate; DTXSID9047839; BAY 54-9085; 5T62Q3B36J; NSC724772; BAY-54-9085; BAY 43-9006 tosylate; DTXCID9027817; CHEBI:50928; RefChem:57444; 641-758-8; Sorafenib tosylate [USAN]; MFCD08235032

Computed molecular descriptors

分子量637.0
氢键供体数4
氢键受体数10
可旋转键数6
精确质量636.1057179
单同位素质量636.1057179
拓扑极性表面积155
重原子数43
形式电荷0
复杂度853

Database abstract

Sorafenib Tosylate · CAS 475207-59-1 · C28H24ClF3N4O6S. UNII 5T62Q3B36J.

Source: PubChem / Wikidata; the batch COA governs where values differ.

You may also need

Get a quote for Sorafenib Tosylate

Supplier: Jinan Shenghe Chemical Co., Ltd. · Reply within one business day.

Email Inquiry WhatsApp
鲁ICP备19031700号-1